Association of tobacco product use with chronic obstructive pulmonary disease (COPD) prevalence and incidence in Waves 1 through 5 (2013–2019) of the Population Assessment of Tobacco and Health (PATH) Study
Authors:
- Laura M. PaulinLPLaura M. Paulin
- Michael J. HalenarMHMichael J. Halenar
- Kathryn C. EdwardsKEKathryn C. Edwards
- Cassandra A. StantonCSCassandra A. Stanton
- Kristie TaylorKTKristie Taylor
- Dorothy HatsukamiDHDorothy Hatsukami
- Andrew HylandAHAndrew Hyland
- Todd MacKenzieTMTodd MacKenzie
- Martin C. MahoneyMMMartin C. Mahoney
Open Access
- 1 October 2022
- journal article
- research article
- Published by Springer Nature in Respiratory Research
- Vol. 23 (1) , 1-13
Abstract
Background: We examined the association of non-cigarette tobacco use on chronic obstructive pulmonary disease (COPD) risk in the Population Assessment of Tobacco and Health (PATH) Study. Methods: There were 13,752 participants ≥ 40 years with Wave 1 (W1) data for prevalence analyses, including 6945 adults without COPD for incidence analyses; W1–5 (2013–2019) data were analyzed. W1 tobacco use was modeled as 12 mutually-exclusive categories of past 30-day (P30D) single and polyuse, with two reference categories (current exclusive cigarette and never tobacco). Prevalence and incidence ratios of self-reported physician-diagnosed COPD were estimated using weighted multivariable Poisson regression. Results: W1 mean (SE) age was 58.1(0.1) years; mean cigarette pack-years was similar for all categories involving cigarettes and exclusive use of e-cigarettes (all > 20), greater than exclusive cigar users (< 10); and COPD prevalence was 7.7%. Compared to P30D cigarette use, never tobacco, former tobacco, and cigar use were associated with lower COPD prevalence (RR = 0.33, (95% confidence interval—CI) [0.26, 0.42]; RR = 0.57, CI [0.47, 0.70]; RR = 0.46, CI [0.28, 0.76], respectively); compared to never tobacco use, all categories except cigar and smokeless tobacco use were associated with higher COPD prevalence (RR former = 1.72, CI [1.33, 2.23]; RR cigarette = 3.00, CI [2.37, 3.80]; RR e-cigarette = 2.22, CI [1.44, 3.42]; RR cigarette + e-cigarette = 3.10, CI [2.39, 4.02]; RR polycombusted = 3.37, CI [2.44, 4.65]; RR polycombusted plus noncombusted = 2.75, CI]1.99, 3.81]). COPD incidence from W2-5 was 5.8%. Never and former tobacco users had lower COPD risk compared to current cigarette smokers (RR = 0.52, CI [0.35, 0.77]; RR = 0.47, CI [0.32, 0.70], respectively). Compared to never use, cigarette, smokeless, cigarette plus e-cigarette, and polycombusted tobacco use were associated with higher COPD incidence (RR = 1.92, CI [1.29, 2.86]; RR = 2.08, CI [1.07, 4.03]; RR = 1.99, CI [1.29, 3.07]; RR = 2.59, CI [1.60, 4.21], respectively); exclusive use of e-cigarettes was not (RR = 1.36, CI [0.55, 3.39]). Conclusions: E-cigarettes and all use categories involving cigarettes were associated with higher COPD prevalence compared to never use, reflecting, in part, the high burden of cigarette exposure in these groups. Cigarette—but not exclusive e-cigarette—use was also strongly associated with higher COPD incidence. Compared to cigarette use, only quitting tobacco was protective against COPD development.Keywords
This publication has 40 references indexed in Scilit:
- Factors associated with undiagnosed and overdiagnosed COPDEuropean Respiratory Journal, 2016
- A Simplified Score to Quantify Comorbidity in COPDPLOS ONE, 2014
- Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS): Table 1Thorax, 2013
- Estimating the U.S. prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007–2010Respiratory Research, 2013
- A fresh look at tobacco harm reduction: the case for the electronic cigaretteHarm Reduction Journal, 2013
- Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysemaBMC Pulmonary Medicine, 2011
- COPD in Never SmokersChest, 2011
- Genetic Epidemiology of COPD (COPDGene) Study DesignCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2010
- The impact of SHS exposure on health status and exacerbations among patients with COPDInternational Journal of Chronic Obstructive Pulmonary Disease, 2009
- Effect of Cigar Smoking on the Risk of Cardiovascular Disease, Chronic Obstructive Pulmonary Disease, and Cancer in MenNew England Journal of Medicine, 1999